Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Identification of rare sequence variation underlying heritable pulmonary arterial hypertensionNature communications, 2018-04, Vol.9 (1), p.1416-16, Article 1416 [Peer Reviewed Journal]2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2018 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-018-03672-4 ;PMID: 29650961Full text available |
|
2 |
Material Type: Article
|
Terminal Digit Preference in Pulmonary Hypertension EndpointsAmerican journal of respiratory and critical care medicine, 2022-06, Vol.205 (12), p.1482-1485 [Peer Reviewed Journal]Copyright American Thoracic Society Jun 15, 2022 ;ISSN: 1073-449X ;EISSN: 1535-4970 ;DOI: 10.1164/rccm.202108-2015LE ;PMID: 35380935Full text available |
|
3 |
Material Type: Article
|
Peripheral microangiopathy in precapillary pulmonary hypertension: a nailfold video capillaroscopy prospective studyRespiratory research, 2021-01, Vol.22 (1), p.27-27, Article 27 [Peer Reviewed Journal]COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1465-993X ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-021-01622-1 ;PMID: 33478514Full text available |
|
4 |
Material Type: Article
|
Exome Sequencing in Children With Pulmonary Arterial Hypertension Demonstrates Differences Compared With AdultsCirculation. Cardiovascular genetics, 2018-04, Vol.11 (4), p.e001887-e001887 [Peer Reviewed Journal]2018 American Heart Association, Inc. ;Copyright American Heart Association, Inc. Apr 2018 ;ISSN: 2574-8300 ;ISSN: 1942-325X ;EISSN: 2574-8300 ;EISSN: 1942-3268 ;DOI: 10.1161/CIRCGEN.117.001887 ;PMID: 29631995Full text available |
|
5 |
Material Type: Article
|
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertensionNature communications, 2019-05, Vol.10 (1), p.2204-17, Article 2204 [Peer Reviewed Journal]The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-10135-x ;PMID: 31101827Full text available |
|
6 |
Material Type: Article
|
Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertensionBMC pulmonary medicine, 2022-07, Vol.22 (1), p.1-281, Article 281 [Peer Reviewed Journal]COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2466 ;EISSN: 1471-2466 ;DOI: 10.1186/s12890-022-01978-0 ;PMID: 35858940Full text available |
|
7 |
Material Type: Article
|
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean heart journal, 2022-10, Vol.43 (38), p.3618-3731 [Peer Reviewed Journal]ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehac237 ;PMID: 36017548Full text available |
|
8 |
Material Type: Article
|
Survival of Japanese Patients with Idiopathic/Heritable Pulmonary Arterial HypertensionThe American journal of cardiology, 2017-05, Vol.119 (9), p.1479-1484 [Peer Reviewed Journal]Elsevier Inc. ;2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 1, 2017 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2017.01.015 ;PMID: 28267959Full text available |
|
9 |
Material Type: Article
|
33 Cardiac MRI thresholds for improvement in pulmonary arterial hypertensionHeart (British Cardiac Society), 2023-01, Vol.109 (Suppl 1), p.A25-A25 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2022-BSCMR.32Full text available |
|
10 |
Material Type: Article
|
Updated Clinical Classification of Pulmonary HypertensionJournal of the American College of Cardiology, 2013-12, Vol.62 (25), p.D34-D41 [Peer Reviewed Journal]American College of Cardiology Foundation ;2013 American College of Cardiology Foundation ;2015 INIST-CNRS ;Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2013.10.029 ;PMID: 24355639 ;CODEN: JACCDIFull text available |
|
11 |
Material Type: Article
|
Pulmonary Arterial Hypertension: Epidemiology and RegistriesJournal of the American College of Cardiology, 2013-12, Vol.62 (25), p.D51-D59 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2013.10.023 ;PMID: 24355642 ;CODEN: JACCDIFull text available |
|
12 |
Material Type: Article
|
Prognostic Value of Echocardiographic Variables Prior to and Following Initiation of Parenteral Prostacyclin TherapyChest, 2022-09, Vol.162 (3), p.669-683 [Peer Reviewed Journal]2022 American College of Chest Physicians ;ISSN: 0012-3692 ;EISSN: 1931-3543 ;DOI: 10.1016/j.chest.2022.04.011Full text available |
|
13 |
Material Type: Article
|
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertensionNature communications, 2019-11, Vol.10 (1), p.5183-18, Article 5183 [Peer Reviewed Journal]2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-13139-9 ;PMID: 31729368Full text available |
|
14 |
Material Type: Article
|
Confusion in connection with pulmonary hypertension due to premature ventricular complexes requires diagnostic work-upEuropean heart journal : case reports, 2023-07, Vol.7 (7), p.ytad321 [Peer Reviewed Journal]COPYRIGHT 2023 Oxford University Press ;ISSN: 2514-2119 ;EISSN: 2514-2119 ;DOI: 10.1093/ehjcr/ytad249 ;PMID: 37501708Full text available |
|
15 |
Material Type: Article
|
Pulmonary Arterial Hypertension and Hereditary Haemorrhagic TelangiectasiaInternational journal of molecular sciences, 2018-10, Vol.19 (10), p.3203 [Peer Reviewed Journal]2018 by the authors. 2018 ;ISSN: 1422-0067 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms19103203 ;PMID: 30336550Full text available |
|
16 |
Material Type: Article
|
Macitentan and Morbidity and Mortality in Pulmonary Arterial HypertensionThe New England journal of medicine, 2013-08, Vol.369 (9), p.809-818 [Peer Reviewed Journal]Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1213917 ;PMID: 23984728 ;CODEN: NEJMAGFull text available |
|
17 |
Material Type: Article
|
A68 WOW: PHARMACOLOGICAL TREATMENT OF PULMONARY HYPERTENSION: Transition From Pde-5 Inhibitors To Riociguat In Pulmonary HypertensionAmerican journal of respiratory and critical care medicine, 2017-01, Vol.195 [Peer Reviewed Journal]Copyright American Thoracic Society 2017 ;ISSN: 1073-449X ;EISSN: 1535-4970Full text available |
|
18 |
Material Type: Article
|
A68 WOW: PHARMACOLOGICAL TREATMENT OF PULMONARY HYPERTENSION: Rationale And Design Of The Replace Trial: Riociguat Replacing Phosphodiesterase 5 Inhibitor (pde5i) Therapy Evaluated Against Continued Pde5i Therapy In Patients With Pulmonary Arterial Hypertension (pah)American journal of respiratory and critical care medicine, 2017-01, Vol.195 [Peer Reviewed Journal]Copyright American Thoracic Society 2017 ;ISSN: 1073-449X ;EISSN: 1535-4970Full text available |
|
19 |
Material Type: Article
|
A18 U GOT THE LOOK: DRUGS, TOXINS, GENES AND RISK ASSESSMENT IN PULMONARY HYPERTENSION: Genetic And Molecular Differences Between Combined And Isolated Post-Capillary Pulmonary HypertensionAmerican journal of respiratory and critical care medicine, 2017-01, Vol.195 [Peer Reviewed Journal]Copyright American Thoracic Society 2017 ;ISSN: 1073-449X ;EISSN: 1535-4970Full text available |
|
20 |
Material Type: Article
|
S91 Patterns of cytokines and growth factors in pulmonary arterial hypertension patients with BMPR2 mutations and PAH patients without driving mutations and their influence on survivalThorax, 2021-02, Vol.76 (Suppl 1), p.A55-A56 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0040-6376 ;EISSN: 1468-3296 ;DOI: 10.1136/thorax-2020-BTSabstracts.96Full text available |